Explore the vast range of titles available.

Gel dosimetry was developed in the 1990s in response to a growing need for methods to validate the radiation dose distribution delivered to cancer patients receiving high-precision radiotherapy. Three different classes of gel dosimeters were developed and extensively studied. The first class of gel dosimeters is the Fricke gel dosimeters, which consist of a hydrogel with dissolved ferrous ions that oxidize upon exposure to ionizing radiation. The oxidation results in a change in the nuclear magnetic resonance (NMR) relaxation, which makes it possible to read out Fricke gel dosimeters by use of quantitative magnetic resonance imaging (MRI). The radiation-induced oxidation in Fricke gel dosimeters can also be visualized by adding an indicator such as xylenol orange. The second class of gel dosimeters is the radiochromic gel dosimeters, which also exhibit a color change upon irradiation but do not use a metal ion. These radiochromic gel dosimeters do not demonstrate a significant radiation-induced change in NMR properties. The third class is the polymer gel dosimeters, which contain vinyl monomers that polymerize upon irradiation. Polymer gel dosimeters are predominantly read out by quantitative MRI or X-ray CT. The accuracy of the dosimeters depends on both the physico-chemical properties of the gel dosimeters and on the readout technique. Many different gel formulations have been proposed and discussed in the scientific literature in the last three decades, and scanning methods have been optimized to achieve an acceptable accuracy for clinical dosimetry. More recently, with the introduction of the MR-Linac, which combines an MRI-scanner and a clinical linear accelerator in one, it was shown possible to acquire dose maps during radiation, but new challenges arise.

The book provides a review of concepts and methodologies developed and adopted for quantitative imaging-guided radiation dosimetry calculations in targeted radionuclide. It also provides an overview of model design of anthropomorphic computational models and software packages developed for Monte Carlo-based dosimetry calculations.

The focus of this study is an intercomparison of laboratories' dose-assessment performances using the γ-H2AX foci assay as a diagnostic triage tool for rapid individual radiation dose assessment. Homogenously Xirradiated blood samples for establishing calibration data as well as blinded test samples were incubated at 37 degree Celsius for 2 and 24 h and sent to the participants. The mean absolute difference (MAD) of estimated doses relative to the actual doses was calculated and radiation doses were merged into four triage categories reflecting clinical relevance to calculate accuracy, sensitivity and specificity. First γ-H2AX based dose estimates were reported 7 h after sample receipt. Estimates were similarly accurate for 2 and 24 h repair times, providing scope for its use in the early phase of a radiation exposure incident. Overall, the results suggest that the γ-H2AX assay is a useful tool for rapidly screening individuals for significant exposures that occurred up to at least 24 h earlier, and may help to prioritize cytogenetic dosimetry follow-up.

Please confirm that an ethics committee approval has been applied for or granted: Not relevant (see information at the bottom of this page)Background and Aims Developing a multidisciplinary approach for nerve pain treatment involves dosimetry, nanobots, and artificial intelligence (AI). Dosimetry calculates radiation dosage to determine the optimal treatment dose based on patient factors. Nanobots target nerve cells or pain receptors, improving precision. AI analyzes patient-specific data to optimize treatment plans. The aim is to revolutionize nerve pain treatment by leveraging dosimetry, nanobots, and AI. Dosimetry ensures personalized treatment, nanobots target specific cells, and AI optimizes plans.MethodsMethods include patient evaluation, dosimetry planning, nanobot design, treatment administration, AI analysis, and treatment refinement. Patient evaluation considers medical history, imaging, and pain intensity. Dosimetry determines optimal dosage. Nanobots are designed to target cells, administered with imaging guidance. AI analyzes dosimetry, imaging, and nanobot data to optimize treatment. Treatment plans are refined based on AI analysis.ResultsResults show promising integration of dosimetry, nanobots, and AI. Dosimetry allows personalized treatment, nanobots enhance precision, and AI optimizes strategies.ConclusionsIn conclusion, the multidisciplinary approach of harnessing dosimetry, nanobots, and AI revolutionizes nerve pain treatment. By providing personalized relief through optimized treatment plans, this approach has the potential to significantly improve the quality of life for individuals suffering from nerve pain.

Thermoluminescence (TL) and optically stimulated luminescence (OSL) are two of the most important techniques used in radiation dosimetry. They have extensive practical applications in the monitoring of personnel radiation exposure, in medical dosimetry, environmental dosimetry, spacecraft, nuclear reactors, food irradiation etc., and in geological /archaeological dating. Thermally and Optically Stimulated Luminescence: A Simulation Approach describes these phenomena, the relevant theoretical models and their prediction, using both approximations and numerical simulation. The authors concentrate on an alternative approach in which they simulate various experimental situations by numerically solving the relevant coupled differential equations for chosen sets of parameters. Opening with a historical overview and background theory, other chapters cover experimental measurements, dose dependence, dating procedures, trapping parameters, applications, radiophotoluminescence, and effects of ionization density. Designed for practitioners, researchers and graduate students in the field of radiation dosimetry, Thermally and Optically Stimulated Luminescence provides an essential synthesis of the major developments in modeling and numerical simulations of thermally and optically stimulated processes.

Radiochromic film (RCF) has several advantageous characteristics which make it an attractive dosimeter for many clinical tasks in radiation oncology. However, knowledge of and strict adherence to complicated protocols in order to produce accurate measurements can prohibit RCF from being widely adopted in the clinic. The purpose of this study was to outline some simple and straightforward RCF fundamentals in order to help clinical medical physicists perform accurate RCF measurements. We describe a process and methodology successfully used in our practice with the hope that it saves time and effort for others when implementing RCF in their clinics. Two RCF analysis software programs which differ in cost and complexity, the commercially available FilmQA Pro package and the freely available ImageJ software, were used to show the accuracy, consistency and limitations of each. The process described resulted in a majority of the measurements across a wide dose range to be accurate within ± 2% of the intended dose using either FilmQA Pro or ImageJ.

The purpose of the EANM Dosimetry Committee is to provide recommendations and guidance to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals labelled with lutetium-177 (177Lu) are increasingly used for therapeutic applications, in particular for the treatment of metastatic neuroendocrine tumours using ligands for somatostatin receptors and prostate adenocarcinoma with small-molecule PSMA-targeting ligands. This paper provides an overview of reported dosimetry data for these therapies and summarises current knowledge about radiation-induced side effects on normal tissues and dose-effect relationships for tumours. Dosimetry methods and data are summarised for kidneys, bone marrow, salivary glands, lacrimal glands, pituitary glands, tumours, and the skin in case of radiopharmaceutical extravasation. Where applicable, taking into account the present status of the field and recent evidence in the literature, guidance is provided. The purpose of these recommendations is to encourage the practice of patient-specific dosimetry in therapy with 177Lu-labelled compounds. The proposed methods should be within the scope of centres offering therapy with 177Lu-labelled ligands for somatostatin receptors or small-molecule PSMA.

Material and Methods: The evaluation of the effective dose as part of individual dosimetry was provided using the film or thermoluminescent dosimetry (TLD). In 2022, the dosimetric service of the Radiological Protection Department of the NIOM covered >30 000 workers employed in >4500 laboratories (mainly health care departments). Conclusions: The data collected in the \"Dosimetry\" database of the NIOM and a detailed analysis of annual doses received by people occupationally exposed to ionizing radiation indicate a well-functioning radiological protection system in Poland. Med Pr Work Health Saf. 2024;75(5):415-423 Key words: occupational exposure, ionizing radiation, individual dosimetry, dose monitoring, thermoluminescent dosimetry, film dosimetry WSTĘP Wykonywanie obowiązków zawodowych związanych ze stosowaniem sztucznych źródeł promieniowania jonizującego w medycynie, nauce i przemyśle wiąże się bezpośrednio z narażeniem na nie personelu.

Purpose In vivo dosimetry is a common requirement to validate dose accuracy/uniformity in total body irradiation (TBI). Several detectors can be used for in vivo dosimetry, including thermoluminescent dosimeters (TLDs), diodes, ion chambers, optically stimulated luminescent dosimeters (OSLDs), and film. TLDs are well established for use in vivo but required expertise and clinical system availability may make them impractical for multifractionated TBI. OSLDs offer quick readout, but recalls have restricted their use. The purpose of this work was to validate the newly available Gafchromic EBT4 film for TBI in vivo dosimetry. Methods Film calibration curves were created under standard conditions (6MV/15MV, 1.5/3.0 cm depth, 100 cm source‐to‐surface distance (SSD), 10 × 10 cm2 field), and films were scanned at several time points (0.5–24 h) to determine the shortest development time that yielded accurate dose measurements. 4 × 4 cm2 films were placed under 1.5 cm thick bolus on the anterior and posterior sides of a solid water phantom to measure entrance and exit dose under TBI conditions (∼600 cm SSD, 39.5 × 39.5 cm2 field, 6 MV/15 MV). These measurements were compared to ion chamber and diode readings for validation. Film measurements were also compared to OSLD measurements for three TBI patients. Results The shortest development time that resulted in accurate dosimetry and allowed for adequate physician review time was 4 h (± 4% dose accuracy). Film entrance and exit dose measurements were within ± 3.8% of ion chamber and diode readings for 6MV and 15MV beams. Patient film measurements were within ∼ ± 5% for the majority of anatomical measurement locations; however, film and OSLD readings for some anatomic locations deviated by > 10%. Conclusions These results indicate that EBT4 film can be utilized for accurate in vivo dosimetry for TBI patients and shows good agreement with diode and ion chamber measurements. Further investigation into film and OSLD differences was not possible due to OSLD recalls.